Pirbuterol
From Wikipedia, the free encyclopedia
For other uses, see Maxair.
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (RS)-6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol | |
| Clinical data | |
| Trade names | Maxair |
| AHFS/Drugs.com | Consumer Drug Information |
| MedlinePlus | a601096 |
| Pregnancy cat. | C |
| Legal status | ℞-only (US) |
| Routes | Inhalational |
| Identifiers | |
| CAS number | 38029-10-6  |
| ATC code | R03AC08 R03CC07 |
| PubChem | CID 4845 |
| DrugBank | DB01291 |
| ChemSpider | 4679  |
| UNII | OG645J8RVW |
| KEGG | D08387 |
| ChEMBL | CHEMBL1094966 |
| Chemical data | |
| Formula | C12H20N2O3 |
| Mol. mass | 240.30 g/mol 300.3 g/mol (acetate) |
|
|
|
|
 (what is this?) (verify) |
Pirbuterol (trade name: Maxair) is a beta-2 adrenergic bronchodilator used in the treatment of asthma, available (as pirbuterol acetate) as a breath-activated metered-dose inhaler ("autohaler").
Contents |
Clinical use [edit]
- Asthma - preventative/maintenance medicine
- Asthma - "rescue" medicine for reversal of acute asthma attack
Mode of action [edit]
Further information: Beta2-adrenergic agonist
Adverse effects [edit]
Further information: Beta2-adrenergic agonist
Source/external link [edit]
|
|
 |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
